Symbols / BNBX Stock $0.50 -6.76% BNB Plus Corp.

Financial Services • Asset Management • United States • NCM
BNBX (Stock) Chart
O: — H: — L: — C: — V: —
SMA 20: — SMA 50: — SMA 200: —
Stock Fundamentals
Scroll to Statements
Index EQUITY
Sector Financial Services
Industry Asset Management
CEO Mr. Clay D. Shorrock Esq., J.D.
Exch · Country NCM · United States
Market Cap 2.81M
Enterprise Value -80.31K
Income -70.16M
Sales 1.83M
FCF (ttm) -17.40M
Book/sh 3.95
Cash/sh 0.45
Employees 26
Insider 10d —
IPO Jul 15, 2003
Div forward ($/yr)
Div TTM ($/yr)
Dividend Yield
Ex-Div Date
5Y Avg Yield
Yield vs 5Y Avg
Payout 0.00%
P/E 0.00
Forward P/E —
PEG 1.27
P/S 1.53
P/B 0.13
P/C —
EV/EBITDA 0.00
EV/Sales -0.04
Quick Ratio 1.36
Current Ratio 2.32
Debt/Eq 0.27
LT Debt/Eq —
EPS (ttm) 282.39
EPS next Y —
EPS Growth —
Revenue Growth -35.00%
EPS Gr Q/Q —
Rev Gr Q/Q —
Earnings (next) 2026-05-15
Earnings (prior) 2025-08-14
ROA -97.97%
ROE -199.14%
ROIC —
Gross Margin 29.91%
Oper. Margin -32.49%
Profit Margin 0.00%
Shs Outstand 5.67M
Shs Float 5.35M
Insider Own 24.10%
Instit Own 1.96%
Short Float 11.98%
Short Ratio 1.22
Short Interest 647.93K
52W High 13.50
vs 52W High -96.33%
52W Low 0.45
vs 52W Low 10.02%
Beta 0.70
Impl. Vol. —
Rel Volume 0.12
Avg Volume 862.00K
Volume 101.97K
Target (mean) —
Tgt Median —
Tgt Low —
Tgt High —
# Analysts —
Recom None
Prev Close $0.53
Price $0.50
Change -6.76%
About

BNB Plus Corp. provides digital asset treasury services. The company offers real-time data tracking of treasury performance and market indicators. The company, through its subsidiaries, also develops and commercializes technologies to produce and detect deoxyribonucleic acid (DNA) and ribonucleic acid (RNA) in the Americas, Europe, Asia, and internationally. The company engages in the enzymatic manufacture of synthetic DNA for use in the production of nucleic acid-based therapeutics and nucleic acid production solutions for the biopharmaceutical and diagnostics industries, including LineaDNA, LineaRNAP, and LineaIVT, as well as the development and sale of a proprietary RNAP for use in the production of mRNA therapeutics. BNB Plus Corp. was formerly known as Applied DNA Sciences, Inc. and changed its name to BNB Plus Corp. in November 2025. The company was founded in 1983 and is based in Stony Brook, New York.

Valuation Models

Price estimates from analyst targets and simple models.

1. Analyst consensus
—
Mean price target
2. Current target
$0.50
Latest analyst target
3. DCF / Fair value
$-55.28
Simplified: (Free Cash Flow ÷ Shares) × 18 (P/FCF multiple). Not a …
Ratings
Current target
$0.50
Low
—
High
—
Mean
—
Insider Transactions
Filed Date Insider Relationship Transaction Shares Price Value SEC
2025-10-17 CATELL ROBERT B Director — 22,511 $0.00 $0
2025-10-17 SHAMASH YACOV A Director — 22,511 $0.00 $0
2025-10-17 MURRAH JUDITH Director — 18,691 $0.00 $0
2025-10-17 CECCOLI JOSEPH D Director — 22,511 $0.00 $0
2025-10-17 JANTZEN BETH M Chief Financial Officer — 18,691 $0.00 $0
2025-10-17 SCHMALZ ELIZABETH M. Director — 22,511 $0.00 $0
2025-10-17 SHORROCK CLAY Chief Executive Officer — 18,691 $0.00 $0
Financials
Statement View
Amounts in millions (2 decimals, no suffix) • EPS per share (2 decimals) • Trend = period evolution • YoY Growth = previous period %
Line Item Trend 2025-09-30 2024-09-30 2023-09-30 2022-09-30
Total Revenue
2.14
+1.11%
2.11
-84.19%
13.37
-26.43%
18.17
Operating Revenue
2.14
+1.11%
2.11
-84.19%
13.37
-26.43%
18.17
Cost Of Revenue
1.30
+14.00%
1.14
-85.47%
7.83
-40.27%
13.12
Reconciled Cost Of Revenue
1.30
+14.00%
1.14
-85.47%
7.83
-40.27%
13.12
Gross Profit
0.84
-13.94%
0.97
-82.38%
5.53
+9.49%
5.05
Operating Expense
16.89
+15.31%
14.64
-11.18%
16.49
-13.33%
19.02
Research And Development
6.02
+67.43%
3.59
-3.78%
3.74
-4.86%
3.93
Selling General And Administration
10.87
-1.64%
11.05
-13.35%
12.75
-15.54%
15.10
Total Expenses
18.18
+15.22%
15.78
-35.11%
24.32
-24.33%
32.14
Operating Income
-16.05
-17.40%
-13.67
-24.79%
-10.95
+21.59%
-13.97
Total Operating Income As Reported
-16.05
-17.40%
-13.67
-24.79%
-10.95
+21.59%
-13.97
EBITDA
-15.66
-18.33%
-13.24
-38.00%
-9.59
+24.36%
-12.68
Normalized EBITDA
-15.98
+20.11%
-20.00
-91.52%
-10.45
+43.29%
-18.42
Reconciled Depreciation
0.38
-11.20%
0.43
-68.24%
1.36
+5.56%
1.29
EBIT
-16.05
-17.40%
-13.67
-24.79%
-10.95
+21.59%
-13.97
Total Unusual Items
0.32
-95.28%
6.77
+692.26%
0.85
-85.11%
5.74
Total Unusual Items Excluding Goodwill
0.32
-95.28%
6.77
+692.26%
0.85
-85.11%
5.74
Special Income Charges
—
—
0.00
0.00
Other Special Charges
—
—
—
—
Impairment Of Capital Assets
—
—
—
0.00
Restructuring And Mergern Acquisition
—
—
0.00
-100.00%
1.67
Net Income
-15.16
-116.81%
-6.99
+29.70%
-9.95
-20.31%
-8.27
Pretax Income
-15.64
-130.42%
-6.79
+32.28%
-10.02
-21.20%
-8.27
Net Non Operating Interest Income Expense
0.19
+60.12%
0.12
+59.93%
0.08
+946.28%
0.01
Net Interest Income
0.19
+60.12%
0.12
+59.93%
0.08
+946.28%
0.01
Interest Income Non Operating
0.19
+60.12%
0.12
+59.93%
0.08
+946.28%
0.01
Interest Income
0.19
+60.12%
0.12
+59.93%
0.08
+946.28%
0.01
Other Income Expense
0.21
-96.85%
6.76
+690.62%
0.86
-84.98%
5.69
Other Non Operating Income Expenses
-0.11
-1100.63%
-0.01
-1482.71%
0.00
+101.36%
-0.05
Gain On Sale Of Security
0.32
-95.28%
6.77
+692.26%
0.85
-85.11%
5.74
Tax Provision
-0.68
0.00
0.00
0.00
Tax Rate For Calcs
0.00
0.00
0.00
0.00
Tax Effect Of Unusual Items
0.01
0.00
0.00
0.00
Net Income Including Noncontrolling Interests
-15.35
-116.54%
-7.09
+29.28%
-10.02
-21.20%
-8.27
Net Income From Continuing Operation Net Minority Interest
-14.77
-120.68%
-6.69
+32.72%
-9.95
-20.31%
-8.27
Net Income From Continuing And Discontinued Operation
-15.16
-116.81%
-6.99
+29.70%
-9.95
-20.31%
-8.27
Net Income Continuous Operations
-14.96
-120.34%
-6.79
+32.28%
-10.02
-21.20%
-8.27
Net Income Discontinuous Operations
-0.39
-30.69%
-0.30
—
—
Minority Interests
0.19
+96.82%
0.10
+26.27%
0.08
+3398.94%
0.00
Normalized Income
-15.07
-11.98%
-13.46
-24.62%
-10.80
+22.89%
-14.01
Net Income Common Stockholders
-69.49
-861.69%
-7.23
+27.36%
-9.95
-18.73%
-8.38
Otherunder Preferred Stock Dividend
54.33
+23207.56%
0.23
0.00
-100.00%
0.11
Diluted EPS
-134.23
+90.18%
-1,366.42
+87.50%
-10,930.83
-12.20%
-9,741.86
Basic EPS
-134.23
+90.18%
-1,366.42
+87.50%
-10,930.83
-12.20%
-9,741.86
Basic Average Shares
0.52
+9689.54%
0.01
+481.10%
0.00
+5.81%
0.00
Diluted Average Shares
0.52
+9689.54%
0.01
+481.10%
0.00
+5.81%
0.00
Diluted NI Availto Com Stockholders
-69.49
-861.69%
-7.23
+27.36%
-9.95
-18.73%
-8.38
Depreciation Amortization Depletion Income Statement
—
—
—
—
Depreciation And Amortization In Income Statement
—
—
—
—
Total Other Finance Cost
—
—
—
—
Line Item Trend 2023-09-30
Total Assets
13.65
Current Assets
8.13
Cash Cash Equivalents And Short Term Investments
7.15
Cash And Cash Equivalents
7.15
Cash Equivalents
—
Receivables
0.26
Accounts Receivable
0.26
Gross Accounts Receivable
0.33
Allowance For Doubtful Accounts Receivable
-0.07
Inventory
0.33
Raw Materials
0.21
Work In Process
0.02
Finished Goods
0.10
Prepaid Assets
—
Assets Held For Sale Current
—
Other Current Assets
0.39
Total Non Current Assets
5.53
Net PPE
2.08
Gross PPE
5.49
Accumulated Depreciation
-3.41
Properties
0.00
Machinery Furniture Equipment
0.06
Other Properties
5.31
Leases
0.12
Goodwill And Other Intangible Assets
2.70
Other Intangible Assets
2.70
Non Current Deferred Assets
—
Non Current Prepaid Assets
0.00
Other Non Current Assets
0.75
Total Liabilities Net Minority Interest
8.78
Current Liabilities
2.85
Payables And Accrued Expenses
2.27
Payables
2.21
Accounts Payable
1.07
Other Payable
1.14
Current Accrued Expenses
0.06
Current Debt And Capital Lease Obligation
0.50
Current Capital Lease Obligation
0.50
Current Deferred Liabilities
0.08
Current Deferred Revenue
0.08
Other Current Liabilities
—
Total Non Current Liabilities Net Minority Interest
5.93
Long Term Debt And Capital Lease Obligation
0.74
Long Term Capital Lease Obligation
0.74
Non Current Deferred Liabilities
0.88
Non Current Deferred Revenue
0.19
Non Current Deferred Taxes Liabilities
0.68
Stockholders Equity
4.95
Common Stock Equity
4.95
Capital Stock
0.00
Common Stock
0.00
Preferred Stock
0.00
Share Issued
0.00
Ordinary Shares Number
0.00
Treasury Shares Number
0.00
Additional Paid In Capital
307.40
Retained Earnings
-302.45
Minority Interest
-0.08
Total Equity Gross Minority Interest
4.87
Total Capitalization
4.95
Working Capital
5.28
Invested Capital
4.95
Total Debt
1.24
Capital Lease Obligations
1.24
Net Tangible Assets
2.25
Tangible Book Value
2.25
Derivative Product Liabilities
4.29
Non Current Accrued Expenses
0.03
Line Item Trend 2025-09-30 2024-09-30 2023-09-30 2022-09-30
Operating Cash Flow
-12.52
+8.70%
-13.71
-120.52%
-6.22
+30.74%
-8.98
Cash Flow From Continuing Operating Activities
-12.24
+9.92%
-13.59
-118.57%
-6.22
+30.74%
-8.98
Cash From Discontinued Operating Activities
-0.28
-127.79%
-0.12
—
—
Net Income From Continuing Operations
-14.96
-120.34%
-6.79
+32.28%
-10.02
-21.20%
-8.27
Depreciation Amortization Depletion
0.38
-11.20%
0.43
-68.24%
1.36
+5.56%
1.29
Depreciation And Amortization
0.38
-11.20%
0.43
-68.24%
1.36
+5.56%
1.29
Other Non Cash Items
—
0.65
—
1.67
Stock Based Compensation
0.10
-82.17%
0.57
-44.65%
1.03
-58.95%
2.52
Provisionand Write Offof Assets
—
0.00
+100.00%
-0.24
-188.71%
0.27
Asset Impairment Charge
2.85
0.00
-100.00%
0.06
0.00
Deferred Tax
-0.68
0.00
—
—
Deferred Income Tax
-0.68
0.00
—
—
Operating Gains Losses
-0.32
+95.68%
-7.40
-760.24%
-0.86
+88.38%
-7.41
Gain Loss On Investment Securities
-0.32
+95.68%
-7.40
-766.37%
-0.85
+88.47%
-7.41
Gain Loss On Sale Of PPE
—
0.00
+100.00%
-0.01
0.00
Change In Working Capital
0.38
+136.09%
-1.06
-143.14%
2.45
+156.31%
0.95
Change In Receivables
-0.01
+95.13%
-0.12
-103.78%
3.05
+672.48%
-0.53
Changes In Account Receivables
-0.01
+95.13%
-0.12
-103.78%
3.05
+672.48%
-0.53
Change In Inventory
0.35
+393.97%
-0.12
-143.56%
0.27
-64.54%
0.77
Change In Prepaid Assets
0.51
+230.48%
-0.39
-151.01%
0.77
+255.67%
-0.49
Change In Payables And Accrued Expense
-0.52
-25.36%
-0.41
+69.50%
-1.35
-245.23%
0.93
Change In Other Working Capital
0.04
+346.46%
-0.02
+93.98%
-0.29
-203.74%
0.28
Investing Cash Flow
-0.29
+28.38%
-0.41
+62.78%
-1.10
-123.84%
-0.49
Cash Flow From Continuing Investing Activities
-0.31
+23.24%
-0.41
+62.78%
-1.10
-123.84%
-0.49
Cash From Discontinued Investing Activities
0.02
0.00
—
—
Net PPE Purchase And Sale
-0.31
+23.24%
-0.41
-1119.52%
-0.03
+93.17%
-0.49
Purchase Of PPE
-0.31
+23.24%
-0.41
-419.97%
-0.08
+83.98%
-0.49
Sale Of PPE
—
0.00
-100.00%
0.04
0.00
Capital Expenditure
-0.31
+23.24%
-0.41
-419.97%
-0.08
+83.98%
-0.49
Net Business Purchase And Sale
—
0.00
+100.00%
-1.06
0.00
Purchase Of Business
—
0.00
+100.00%
-1.06
0.00
Net Intangibles Purchase And Sale
—
—
—
—
Purchase Of Intangibles
—
—
—
—
Financing Cash Flow
8.05
-39.89%
13.40
0.00
-100.00%
18.13
Cash Flow From Continuing Financing Activities
8.05
-39.89%
13.40
0.00
-100.00%
18.13
Net Issuance Payments Of Debt
—
—
—
0.00
Issuance Of Debt
—
—
—
—
Repayment Of Debt
—
—
—
0.00
Long Term Debt Issuance
—
—
—
—
Long Term Debt Payments
—
—
—
0.00
Net Long Term Debt Issuance
—
—
—
0.00
Net Common Stock Issuance
5.71
-57.36%
13.40
0.00
-100.00%
14.43
Proceeds From Stock Option Exercised
2.51
+636481.98%
0.00
0.00
-100.00%
3.70
Net Other Financing Charges
-0.17
—
—
—
Changes In Cash
-4.76
-559.95%
-0.72
+90.15%
-7.31
-184.45%
8.66
Beginning Cash Position
7.18
-9.12%
7.90
-48.07%
15.22
+132.12%
6.55
End Cash Position
2.42
-66.23%
7.18
-9.12%
7.90
-48.07%
15.22
Free Cash Flow
-12.83
+9.12%
-14.12
-124.25%
-6.30
+33.49%
-9.47
Interest Paid Supplemental Data
0.00
0.00
0.00
0.00
Income Tax Paid Supplemental Data
0.00
0.00
0.00
0.00
Common Stock Issuance
5.71
-57.36%
13.40
0.00
-100.00%
14.43
Issuance Of Capital Stock
5.71
-57.36%
13.40
0.00
-100.00%
14.43
SEC Filings

Recent 10-K, 10-Q, 8-K, and Form 4 (insider) filings.

Trades
Date User Broker Pattern Type Position Size Entry Price Trade P&L Status
Posts
Published Title Author Category